5-[2-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]amino]-1-hydroxyethyl]benzene-1,3-diol

This compound is a deuterium-labeled active pharmaceutical ingredient, specifically a stable isotope-labeled form of a beta-adrenergic receptor agonist. Its primary significance lies in its use as an internal standard or reference compound in pharmaceutical research and development.